Cannabis Compounds May Reverse One of the World’s Most Common Diseases

By Justice — Elevated Club NYC

New research suggests that compounds found in cannabis could help treat one of the most common chronic health conditions affecting adults today: metabolic dysfunction-associated steatotic liver disease (MASLD) — commonly known as fatty liver disease.

MASLD affects roughly one-third of adults worldwide, making it the most common chronic liver disorder. The condition is closely linked to obesity, insulin resistance, and metabolic syndrome, and it currently has very limited pharmaceutical treatment options.

A recent study published in the British Journal of Pharmacology examined how two non-intoxicating cannabinoids — CBD (cannabidiol) and CBG (cannabigerol) — affect liver metabolism. Researchers discovered that these compounds significantly reduced fat buildup in the liver and improved metabolic health in experimental models.

Unlike THC, the compound responsible for cannabis’s psychoactive effects, CBD and CBG do not produce a “high.” This makes them especially interesting for potential medical therapies that could be used long-term.

The researchers identified a process called “metabolic remodeling.” In simple terms, the cannabinoids helped the liver produce more energy and improve cellular cleanup systems that break down excess fats. This allowed the liver to function more efficiently even under metabolic stress.

CBG appeared particularly promising in the study. Scientists observed reductions in body fat, LDL cholesterol levels, and improvements in insulin sensitivity — key markers tied to metabolic disease.

However, experts caution that these findings are still preclinical, meaning they were observed in controlled laboratory models. Human clinical trials will be necessary before cannabis-derived therapies could become standard treatments.

Still, the research highlights something the cannabis conversation often misses: the plant contains dozens of biologically active compounds, many of which are still being studied for their medical potential.

For an industry often reduced to THC percentages and strain names, discoveries like this show the deeper scientific frontier behind cannabis.

At Elevated Club NYC, we believe education is elevation. As cannabis research continues to expand, understanding the plant beyond recreational use will become increasingly important — not just for consumers, but for the future of medicine.

Stay Elevated.